Chemicals and Drugs [D] » Pharmaceutical Preparations [D26] » Drugs, Investigational
Description
Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries. MeSH
Hierarchy View
Phase 4 Indicated Drugs (109)
porcine brain-derived peptide preparation (cerebrolysin)
rabies vaccine (purified chick embryo cell vaccine) (RabAvert)
Phase 2 Indicated Drugs (93)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23)
allogeneic natural killer cells
anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil)
lutetium dotatate lu-177 (Lutathera)
multi-valent pneumococcal conjugate vaccine
Phase 1 Indicated Drugs (72)
Other Experimental Indicated Drugs (94)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
